Vector Core
矢量核心
基本信息
- 批准号:7450502
- 负责人:
- 金额:$ 12.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adenovirus VectorAdenovirusesAnimalsArchivesAreaArtsBasic ScienceBiodistributionBiological AssayClinicalControl GroupsDatabasesDependovirusDevelopmentDiseaseDocumentationEquipmentGene DeliveryGene TransferGenerationsGenomeGuanosine MonophosphateGuidelinesLaboratoriesLentivirus VectorLinkLocationMapsMediatingMethodologyMethodsMolecular BiologyNumbersOutcomePennsylvaniaPhase I Clinical TrialsPolymerase Chain ReactionProceduresProcessProductionQuality ControlRangeReagentRegulationResearchResearch PersonnelResourcesScientistScreening procedureSeriesSerotypingServicesSomatic Gene TherapyStandards of Weights and MeasuresSubfamily lentivirinaeTechnologyTimeTime StudyTissuesTrainingUniversitiesValidationViral Vectorbasedesignexperiencegene therapyimprovedin vivoinnovationinterestnovelpreclinical studyprogramsquality assurancerepositoryurea cyclevectorvector genome
项目摘要
Vector Core
The Vector Core at the University of Pennsylvania is an independent and full service laboratory providing
reagents and expertise in the area of gene transfer. This facility called "Penn Vector" is directed by Dr. Julie
Johnston who manages 7 scientists in the area of AAV, adenovirus and lentiviral production. This program
will focus on utilization of Penn vector for the production of AAV vectors that will service Projects I through III
An independent Quality Control Program directed by Dr. Martin Lock performs a series of assays necessary
for release of the vector for in vivo studies. This core will also analyze tissues for presence of vector
genomes using TaqMan and PCR technology. Finally, the Vector Core will adapt existing methods of
manufacturing and purification to the clinical candidate for a large scale production efficient enough to
support large animals in a Phase 1 study. Assays necessary to support the ultimate clinical production will
also be developed. The laboratory operates under the general principles of GLP including, documentation
(batch record forms), SOPs, QA/QC, training and equipment validation, although it does not represent itself
as being fully GLP or GMP.
Lay description. All vectors used in the P01 will be. created and produced by the Vector Core.
Vector Core
宾夕法尼亚大学的Vector Core是一个独立的全方位服务实验室,
基因转移领域的试剂和专业知识。这个名为“Penn Vector”的设施由朱莉博士
约翰斯顿,他管理着AAV、腺病毒和慢病毒生产领域的7位科学家。这个程序
将集中于利用Penn载体生产AAV载体,这些载体将服务于项目I至III
由Martin Lock博士指导的独立质量控制程序执行一系列必要的测定
用于释放载体用于体内研究。该核心还将分析组织中是否存在载体
利用TaqMan和PCR技术进行基因组测序。最后,Vector Core将采用现有的方法,
用于大规模生产的临床候选药物的生产和纯化足够有效,
在1期研究中支持大型动物。支持最终临床生产所需的测定将
也要发展。实验室在GLP的一般原则下运行,包括文件
(批记录表)、SOP、QA/QC、培训和设备验证,但不代表其自身
符合GLP或GMP标准。
Lay描述。P01中使用的所有载体均为。由矢量核心创造和生产。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JULIE JOHNSTON其他文献
JULIE JOHNSTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JULIE JOHNSTON', 18)}}的其他基金
GENE THERAPY RESOURCE PROGRAM (GTRP): TASK AREA B FOR PRECLINICAL VECTOR CORE LABORATORY SCIENTIFIC ACTIVITIES
基因治疗资源计划 (GTRP):临床前载体核心实验室科学活动的任务领域 B
- 批准号:
10725221 - 财政年份:2022
- 资助金额:
$ 12.29万 - 项目类别:
GENE THERAPY RESOURCE PROGRAM (GTRP): TASK AREA B FOR PRECLINICAL VECTOR CORE LABORATORY SCIENTIFIC ACTIVITIES
基因治疗资源计划 (GTRP):临床前载体核心实验室科学活动的任务领域 B
- 批准号:
10788012 - 财政年份:2022
- 资助金额:
$ 12.29万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 12.29万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 12.29万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 12.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 12.29万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 12.29万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 12.29万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 12.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 12.29万 - 项目类别:
Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 12.29万 - 项目类别:
Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 12.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




